Uncategorized Archives - Oncology Central Oncology Central

Discover a patients perspective on tumor mutation burden as a possible pathway for improvements in immuno-oncology. #OCtmb. Click on the image below for the full perspective: https://t.co/sywtJpAqz0

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Vote for your winner of the Capturing Cancer: Oncology Central Photography Competition

Instagram

In Focus: Breast Cancer

Speaker: Kim Buxton (Loughborough University, UK)

Speaker: Karan Thomas (Health Development Consultancy)

Speaker: Susannah Brown (World Cancer Research Fund International, UK)

Thank you for requesting our ‘Sponsorship opportunities’ pack

Tamoxifen, SERMs and sustainable medicine

Thank you for requesting our ‘Sponsorship opportunities’ pack

Immune checkpoint inhibitors for hepatocellular carcinoma

Study further elucidates the mechanism of brain cancer spread

ESMO16: Pembrolizumab shows therapeutic potential in non-small-cell lung cancer

ESMO16: Phase I study of novel anticancer drug identifies responders via tumor mRNA

ASTRO16 news round-up

Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization

Conformal radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: is it safe?

First results from ProtecT trial in prostate cancer published

GE Healthcare: Innovation to improve breast cancer diagnostics

Role of rare germline copy number variation in melanoma-prone patients

Clinical relevance of the molecular landscape in cancers of unknown primary

Melanoma: when physician becomes patient

Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma

US FDA grant approval of pembrolizumab for advanced head & neck cancer

Low-dose brachytherapy strategies to treat uveal melanoma: is less more?

Login

Uncategorized

Must read

Vote for your winner of the Capturing Cancer: Oncology Central Photography Competition

Instagram

In Focus: Breast Cancer

Speaker: Kim Buxton (Loughborough University, UK)

Speaker: Karan Thomas (Health Development Consultancy)

Speaker: Susannah Brown (World Cancer Research Fund International, UK)

Thank you for requesting our ‘Sponsorship opportunities’ pack

Must watch

Tamoxifen, SERMs and sustainable medicine

Seven challenges in immuno-oncology

The importance of a multidisciplinary team in the care of head and neck cancer

Overcoming challenges in cell line engineering

Thank you for requesting our ‘Sponsorship opportunities’ pack

Immune checkpoint inhibitors for hepatocellular carcinoma

Study further elucidates the mechanism of brain cancer spread

ESMO16: Pembrolizumab shows therapeutic potential in non-small-cell lung cancer

ESMO16: Phase I study of novel anticancer drug identifies responders via tumor mRNA

ASTRO16 news round-up

Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization

Conformal radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: is it safe?

First results from ProtecT trial in prostate cancer published

GE Healthcare: Innovation to improve breast cancer diagnostics

Role of rare germline copy number variation in melanoma-prone patients

Clinical relevance of the molecular landscape in cancers of unknown primary

Melanoma: when physician becomes patient

Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma

US FDA grant approval of pembrolizumab for advanced head & neck cancer

Low-dose brachytherapy strategies to treat uveal melanoma: is less more?

Stay up to date

Oncology Central Newsletter